đź“Š Evidence-Based Reference
hemodialysis bath concentrate solutions for hemodi
Dial Medical Of Florida
Summary: Hemodialysis bath concentrate solutions are used in dialysis to manage acid-base balance in patients with renal failure. Key evidence highlights variations in acid-base homeostasis during treatment.
FDA Clearance Information
Pathway
510K
Number
K864265 ↗
Decision Date
March 17, 1987
Product Code
KPO
Device Class
Class 2
Evidence
0 studies
The device was cleared by the FDA through the 510(k) pathway on March 17, 1987. It is manufactured by Dial Medical Of Florida and classified as a Class 2 device.
What It Is
Hemodialysis bath concentrate solutions are used in dialysis machines to help manage the acid-base balance in patients undergoing hemodialysis. They are designed to facilitate the removal of waste products and excess substances from the blood.
Clinical Applications
These solutions are commonly used in clinical settings for patients with end-stage renal disease requiring hemodialysis. They are integral in maintaining electrolyte balance and preventing complications associated with renal failure.
Evidence Summary
The available literature includes a mix of study types such as RCTs, prospective, and retrospective studies. The studies span from 2020 to 2023, providing insights into the device's impact on acid-base balance during dialysis.
Reported Outcomes
Published studies report that hemodialysis using these solutions can affect acid-base homeostasis, with variations in bicarbonate and CO2 levels. Some studies highlight the potential for respiratory alkalosis and acidosis during treatment.
Safety Profile
Reported complications include unexpected occurrences of respiratory alkalosis and acidosis during hemodialysis. These findings suggest the need for careful monitoring of acid-base balance during treatment.
Evidence Limitations
The evidence is limited by the variability in study designs and small sample sizes. Further research is needed to explore long-term outcomes and optimize bicarbonate prescriptions for different patient populations.
Frequently Asked Questions
What are the clinical indications for hemodialysis bath concentrate solutions?
These solutions are indicated for use in patients undergoing hemodialysis to manage acid-base balance and electrolyte levels.
What outcomes have been reported in clinical studies?
Studies report variations in acid-base homeostasis, including changes in bicarbonate and CO2 levels, and occurrences of respiratory alkalosis and acidosis.
What complications have been reported?
Safety data indicate potential complications such as respiratory alkalosis and acidosis during hemodialysis treatment.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.